SCHEDULE: Vanguard Reports 0% Teladoc Stake After Internal Realignment

The Vanguard Group has amended its Schedule 13G for Teladoc Health Inc., reporting 0% beneficial ownership following an internal corporate realignment.

Summary

• The Vanguard Group filed Amendment No. 10 to its Schedule 13G for Teladoc Health Inc. common stock.
• The filing reports 0% beneficial ownership of Teladoc Health Inc. common stock by The Vanguard Group.
• This change is a direct result of an internal realignment within The Vanguard Group, which became effective on January 12, 2026.
• Following this realignment, specific subsidiaries or business divisions of The Vanguard Group, Inc. will now report their beneficial ownership separately (on a disaggregated basis).
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over the securities beneficially owned by these separate subsidiaries and/or business divisions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as a procedural update reflecting an internal corporate realignment at The Vanguard Group, rather than a change in investment sentiment towards Teladoc Health Inc.

Risks

• Potential for misinterpretation by investors regarding The Vanguard Group's overall exposure to Teladoc Health Inc., despite the explanation of internal realignment.

Future Outlook

No forward-looking statements or guidance regarding Teladoc Health Inc. are provided in this filing.

Management Comments

• On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.

Industry Context

StockSavvy.ai notes that such internal realignments and subsequent changes in beneficial ownership reporting are not uncommon among large asset managers like Vanguard, often driven by regulatory interpretations or internal operational efficiencies. This specific filing clarifies how Vanguard's holdings in Teladoc Health Inc. will be reported moving forward, rather than indicating a change in investment strategy towards Teladoc by Vanguard's broader ecosystem.

Stakeholder Impact

• Shareholders of Teladoc Health Inc. may observe a change in reported institutional ownership data, which could be misinterpreted without understanding the underlying reason for Vanguard's disaggregated reporting.
• Investment professionals tracking institutional holdings will need to adjust their models to account for The Vanguard Group's new reporting methodology for its subsidiaries.

Key Dates

Keywords

Teladoc Health Inc, Vanguard Group, Schedule 13G, beneficial ownership, common stock, SEC filing, institutional ownership, corporate realignment